
Amplify Weight Loss Drug & Treatment ETF issues dividends to shareholders from excess cash Amplify Weight Loss Drug & Treatment ETF generates. Most companies pay dividends on a quarterly basis, but dividends may also be paid monthly, annually or at irregular intervals.
Amplify Weight Loss Drug & Treatment ETF does not currently pay a dividend or dividend information is unavailable.
Amplify Weight Loss Drug & Treatment ETF last traded ex-dividend on Dec 30 and the next ex-dividend date is scheduled for Dec 30.
Last Dividend
Dec 30
Next Dividend
Dec 30
Amplify Weight Loss Drug & Treatment ETF's next dividend was announced on December 29, 2026 and will have an ex-dividend date of December 30, 2026.
The next dividend payout for Amplify Weight Loss Drug & Treatment ETF (THNR) will be on December 31, 2026. Investors need to be owners of Amplify Weight Loss Drug & Treatment ETF (THNR) shares by December 30, 2026.
The next dividend for Amplify Weight Loss Drug & Treatment ETF (THNR) will be on December 31, 2026 and will be $0.41.
The most current yield for Amplify Weight Loss Drug & Treatment ETF (THNR) is 0% and is payable next on December 31, 2026.
The next dividend for Amplify Weight Loss Drug & Treatment ETF (THNR) was announced on December 29, 2026.
There is not enough data to provide an evaluation.
There is not enough data to provide an evaluation.
There is not enough data to provide an evaluation.